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Background: Carotid endarterectomy is beneficial in severe (>70%) symptomatic carotid stenosis. The risk of stroke in
moderate carotid stenosis (50%-69%) is modest, and so the role of carotid endarterectomy in this group is unclear.
Intraplaque hemorrhage is associated with advanced atherosclerosis and can be detected in the carotid arteries by
magnetic resonance imaging. This study evaluates whether magnetic resonance imaging detected intraplaque hemorrhage
(MR IPH) can identify patients with symptomatic mild to moderate carotid stenosis who are at higher risk of ipsilateral
transient ischemic attack (TIA) and stroke.
Methods:Prospective longitudinal cohort study of symptomatic patients withmild tomoderate (30%-69%) carotid stenosis
followed up for 2 years after imaging for IPH using magnetic resonance imaging.
Results: Sixty four participants were followed up for a median of 28 months (interquartile range 26-30) after MRI of the
carotid arteries. Thirty-nine (61%) ipsilateral arteries showed intraplaque hemorrhage. During follow-up, five ipsilateral
strokes and a total of 14 ipsilateral ischemic events were observed. Thirteen of these ischemic events, of which five were
strokes, occurred in those with ipsilateral carotid intraplaque hemorrhage (hazard ratio  9.8, 95% confidence interval
1.3-75.1, P  .03).
Conclusions: MR IPH is a good predictor of ipsilateral stroke and TIA in patients with symptomatic mild to moderate
(30%-69%) carotid stenosis. This technique could help in the selection of patients for carotid endarterectomy. (J Vasc
Surg 2008;47:337-42.)Ischemic strokes and transient ischemic attacks (TIA)1
are commonly caused by thromboembolization from rup-
tured carotid atherosclerotic plaques. Large trials of the
effects of carotid endarterectomy (CEA) showed that the
risks of such surgery were clearly outweighed by the bene-
fits in high risk patients with high grade carotid stenosis.2,3
The risk to benefit ratio of CEA was less clear cut in
symptomatic patients with moderate (50%-69%) stenosis.
Indeed, some authors argue that CEA in those with mod-
erate stenosis is not cost effective.4 Intervening in an iden-
tifiable subgroup of patients who are at a high risk of stroke
may improve the risk to benefit ratio.
Primary investigations used in suspected carotid artery
disease involves estimating the degree of stenosis, most
usually using carotid Doppler ultrasonography or magnetic
resonance (MR) angiography. In recent years, imaging
technologies have been developed to examine carotid
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doi:10.1016/j.jvs.2007.09.064plaque morphology with the aim of identifying pathologi-
cal features other than the degree of stenosis, to provide
more sensitive and specific identification of clinically rele-
vant carotid disease, and hence, improve targeting of inter-
ventions. One such approach is to look for the presence of
complicated plaque, a feature of which is intraplaque hem-
orrhage (IPH).5-7 Intraplaque hemorrhage is thought to
be caused by rupture of the fragile and tortuous neovessels
formed within the plaque.6 IPH is considered to be an
important atherogenic stimulus by contributing cholesterol
to the necrotic core of the plaque and increasing macro-
phage infiltration, making the plaque more unstable.7
However, from the known pathophysiology, IPH
would be expected to be seen in some plaques that have not
ruptured and indeed is seen in many asymptomatic arter-
ies.7,8 Therefore uncertainty remains as to whether IPH is a
clinically valid predictor of stroke or TIA in patients pre-
senting with carotid artery disease.
In patients with symptomatic carotid disease, histolog-
ical studies show that high signal on a T1 weighted mag-
netic resonance imaging sequence can be used to identify
IPH accurately9 and can distinguish histological compli-
cated carotid plaque from uncomplicated atherosclerotic
disease.10 Some data exist to support the notion that this
intraplaque high signal is a clinically valid biomarker of
further TIA and/or stroke.11,12 It predicts those symptom-
atic patients with high grade carotid stenosis who develop
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carotid endarterectomy11 and it is associated with increased
ipsilateral microembolization (as detected by transcranial
Doppler ultrasound) during carotid endarterectomy.13
The predictive value of intraplaque high signal in nonsur-
gical populations is not known.
We therefore undertook a prospective cohort study of
patients presenting with stroke and TIA, with mild and
moderate (30%-69%) stenosis, to establish the value of
magnetic resonance imaging detected intraplaque hemor-
rhage (MR IPH) in the prediction of recurrent TIA and
stroke. Given the clinical uncertainty of the value of carotid
endarterectomy in people with moderate carotid stenosis
(50%-69%), we undertook a subanalysis of this group.
METHODS
Study population. All patients identified from the
TIA clinic at the Queen’s Medical Centre, Nottingham
with amaurosis fugax, hemispheric TIA, or nondisabling
stroke and mild to moderate carotid stenosis (30%-69%)
ipsilateral to the affected hemisphere were invited to partic-
ipate, unless they had contraindications to magnetic reso-
nance imaging (MRI) scanning or they had a life expect-
ancy of less than 2 years. All patients were given lifestyle
advice and medically treated with an antiplatelet agent,
statin, and antihypertensives, as clinically indicated. Carotid
endarterectomy or stenting were not routinely offered to
patients with 69% stenosis in our institution. The local
research ethics committee approved the study and all par-
ticipants gave informed consent.
Ultrasound scanning. Carotid Duplex studies were
performed using a Truscan Logiq 9 ultrasound machine
(General Electric, Milwaukee, Wis) by an experienced ac-
credited vascular technologist. Using a 12, 9, or a 7 MHz
ultrasound probe to visualize the carotid bifurcation, ca-
rotid stenosis was determined by assessing the velocities in
the longitudinal section using a variable Doppler angle
60 degree. Using ultrasound criteria14 adapted from the
angiographic measurements of the North American Symp-
tomatic Carotid Surgery Trial as used in the Carotid and
Vertebral Artery Transluminal Angioplasty Study,15 the
degree of stenosis was graded as minimal (0%-29%), mild
(30%-49%), moderate (50%-69%), severe (70%-99%), and
occlusion. All but two of the carotid Duplex scans were of
appropriate quality for the determination of the stenosis.
The degree of stenosis in the patients with equivocal Du-
plex scans was confirmed as being moderately stenosed
using magnetic resonance angiography.
MRI scanning and analysis. Consenting participants
underwent MRI scanning, performed on a 1.5 T Vision
scanner (Siemens, Erlangen, Germany) using a receive-only
quadrature neck array cervical spine coil.MRI of the carotid
plaque was performed as previously described10 using a
coronal T1-weighted magnetization-prepared three-
dimensional gradient echo sequence with selective water-
excitation to abolish fat (TR 10.3ms, TE 4.0ms, FA 15, TI
20 ms, FOV 350  300 mm, matrix 256  140,140
partitions, volume thickness 120 to 150 mm). The numberof partitions and TI were chosen such that the effective TI
allowed to null blood signal. The acquisition took 3.5
minutes.
Image analysis was performed off-line read using stan-
dard image reconstruction techniques as provided by JAVA
Imaging (JIM) software (www.xinapse.com). Presence of
intraplaque hemorrhage was determined independently by
two trained researchers blinded to the clinical data. IPH
was diagnosed if a hyperintense (high) signal was seen
within the wall of the carotid artery between 1 cm above
and below the bifurcation compared with the adjacent
muscle (Fig 1). In scans which were deemed to be equivocal
by any of the researchers (n  14), a consensus was then
reached between the two trained researchers and an expe-
rienced neuroradiologist blinded to the clinical data. The
result of this consensus exercise was that IPH was deemed
to be present if the maximal signal intensity within the
plaque was150% than the signal intensity in the adjacent
sternomastoid muscle. The size of the hyperintense signals
varied from 9.7 mm2 to 32.6 mm2. The presence or ab-
sence of high signal (MR IPH positive or negative, respec-
tively) was recorded in both the symptomatic and asymp-
tomatic (contralateral) arteries. Interobserver variability,
assessed on 120 arteries, showed excellent agreement be-
tween the two researchers and between the neuroradiolo-
gist, and each of the researchers (Cohen’s  varied between
0.80 and 0.88).
Clinical assessment. Participants were interviewed
and examined by a medically trained researcher for any
cerebrovascular events (stroke, transient ischemic attack, or
amaurosis fugax) at entry to the study, then at 3, 12, and 24
months and if they developed symptoms in the interim
periods. In all such cases, the diagnosis of ischemic recur-
rence was verified by the medical records, and all strokes
were confirmed as ischemic by neuroimaging. The clinical
assessments and follow-up were performed blinded to the
Fig 1. Axial image demonstrating intraplaque hemorrhage as
shown by a hyperintense left internal carotid plaque (arrow) in a
moderately stenosed carotid artery.results of the MRI scanning results.
trapla
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performed using SPSS (11.0) and statistical significance was
defined P  .05. 2 and Mann-Whitney tests were used to
compare categorical and continuous demographic and risk
factors between groups with and without MR intraplaque
hemorrhage. The effect of intraplaque hemorrhage on the
rate of subsequent recurrent cerebral ischemic events
(stroke, TIA, and amaurosis fugax) was examined using
Kaplan-Meier analysis. Univariate analyses were also carried
out using Cox regression for intraplaque hemorrhage and
other risk factors. Further subgroup analysis was performed
in those with just moderate carotid stenosis (50%-69%)
using Kaplan Meier analysis. Due to the small number of
stroke events in this series, statistical testing was only per-
formed on all recurrent ischemic events. Multivariate anal-
ysis was not undertaken for the same reason.
RESULTS
Of 113 symptomatic patients with mild and moderate
carotid stenosis identified between September 2002 and
November 2003, one was ineligible due to a pacemaker and
another because of lung cancer, and 38 declined. Seventy-
three participants entered the study but eight were unable
to complete the scan due to claustrophobia and one patient
with a stenosis30% was entered in error, leaving a total of
64 who were available for analysis. There were no patients
lost in the follow-up period. Participants had a median age
of 72.7 years (interquartile range 65.0-78.3) and 51 (80%)
were male. Twenty-two (34%) participants had ipsilateral
carotid stenosis of 30% to 49%, and 42 (66%) had stenosis
Table I. Participant characteristics of groups with and wit
study
Age (median [IQR])
Sex – female (%)
Hypertension (%)

















Median days between symptom and MRI (IQR)
IQR, Interquartile range;MR IPH,magnetic resonance imaging detected in
imaging.of 50% to 69%. The MR image quality was good in all casesand 39 (61%) ipsilateral arteries showed high signal (in-
traplaque hemorrhage). In the moderate stenosis sub-
group, 27 of the 42 ipsilateral carotid arteries had MR IPH
(64%); and 12 of the 22 ipsilateral carotid arteries had MR
IPH (55%) in the mild stenosis subgroup.
On the contralateral (asymptomatic) side, there were
36 (56%) arteries with 0% to 29% stenosis, 8 (13%) arteries
with 30% to 49% stenosis, 8 (13%) with 50% to 69%
stenosis, and 12 (19%) arteries with high grade carotid
stenosis or occlusion. Thirty-seven (58%) of the contralat-
eral carotid arteries had high signal (22 [60%] of which had
0% to 29% stenosis, 4 [11%] had mild, 4 [11%] moderate,
and 7 [19%] had high grade stenosis and/or occlusion).
Participant characteristics are shown in Table I. There
was no association between the prevalence of ipsilateral MR
IPH and the degree of carotid stenosis (Table I).
The median duration of clinical follow-up of the 64
participants was 28 months (interquartile range 26-30
months), during which 14 ischemic neurological events
(stroke, TIA, and amaurosis fugax) ipsilateral to the index
event, of which five were strokes, were detected. In 12
cases, these events were identified shortly after occurrence
between scheduled follow-up visits and the remaining two
were identified at a scheduled visit and verified by referral to
the medical records.
Thirteen of these ischemic events (including all strokes)
occurred in those with ipsilateral arteries with high signal
(intraplaque hemorrhage). The single TIA ipsilateral to the
index event that occurred in the participants whose ipsilat-




(n  25, 39% ) P value
(65.0-80.2) 69.5 (64.3-75.7) .3
(10) 10 (40) .05
(80) 19 (76) .7
(15) 4 (16) .9
(26) 3 (12) .2
(69) 18 (72) .8
(77) 18 (72) .8
(31) 10 (40) .5
(69) 15 (60)
(83) 21 (84)
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(21.0-36.0) 34.0 (27.0-43.5) .1




















31.0eral carotid arteries showed no MR IPH (n 25) had 30%
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cated coronary artery catheterization.
In subanalysis of the 42 participants with 50% to 69%
(moderate) carotid stenosis 10 events (of which five were
strokes) occurred (rate  24%), and four events (none of
which were strokes) occurred in the 22 with 30% to 49%
(mild) stenosis (rate  18%) (Table II). Ten of the 27
ipsilateral carotid arteries with MR IPH and in the moder-
ate stenosis group (37%) had a recurrent event over the
28-month period and three of the 12 ipsilateral carotid
arteries with MR IPH and in the mild stenosis group (25%)
had a recurrent event.
There were no posterior circulation events, no con-
tralateral strokes, and only one contralateral TIA during
follow-up: this participant’s carotid arteries had bilateral
high signal and 50% to 69% stenosis f the supplying carotid
Fig 2. Kaplan-Meier survival curves of participants remaining
event free (of ipsilateral cerebral ischemic events) in the groups
with and without MR detected intraplaque hemorrhage (MR
IPH) in the symptomatic artery of all patients.
Table II. Number of ipsilateral strokes and ischemic
events according to degree of stenosis and magnetic








In participants with 30% to 49%
stenosis (n  22) 0 4 (18)
MR IPH:
present (n  12) 0 3 (25)
absent (n  10) 0 1 (10)
In participants with 50% to 69%
stenosis (n  42) 5 10 (24)
MR IPH:
present (n  27) 5 (19) 10 (37)
absent (n  15) 0 0
MR IPH, Magnetic resonance detected intraplaque hemorrhage.artery.Kaplan Meier survival plots illustrate the difference in
the event free survival between those with and without high
signal (intraplaque hemorrhage) in the symptomatic artery
(log rank test  7.4, P  .007, Fig 2). Univariate Cox
regression analysis further demonstrated that the presence
of high signal (intraplaque hemorrhage) significantly pre-
dicted ischemic recurrence (stroke, TIA, and amaurosis
fugax) with a hazard ratio (HR) of 9.8 (95% confidence
interval [CI] 1.3-75.1), whereas all other patient-related
factors we measured did not, including the degree of ste-
nosis (HR 1.5; 95% CI 0.5-4.9) (Table III). The number
of strokes, as opposed to strokes and TIAs, was insufficient
to permit reliable statistical analysis.
Kaplan Meier analysis (Fig 3) of the sub group with
50% to 69% (moderate) carotid stenosis (n  42) demon-
strate that the presence of high signal (intraplaque hemor-
rhage) also decreased the event free survival (log rank test
6.4, P  .01). Due to the small sample size of this sub-
Table III. Univariate Cox regression analysis of factors
affecting ischemic ipsilateral recurrent events in all
patients
Hazard ratio
(95% CI) P value
Age 1.0 (0.9-1.0) .1
Sex (female) 0.6 (0.1-2.8) .6
Hypertension 1.8 (0.4-7.8) .5
Ischemic heart disease 0.4 (0.1-3.3) .4
Diabetes mellitus 1.4 (0.4-4.5) .6
Smoker 1.3 (0.4-4.8) .7
Degree of ipsilateral stenosis 1.5 (0.5-4.9) .5
Time from last symptom and MRI 0.99 (0.95-1.04) .7
Intraplaque hemorrhage present 9.8 (1.3-75.1) .03
MRI, Magnetic resonance imaging.
Fig 3. Kaplan-Meier survival curves of participants remaining
event free (of ipsilateral cerebral ischemic events) in the groups
with and without MR detected intraplaque hemorrhage (MR
IPH) in the symptomatic artery of those patients with moderate
grade carotid stenosis only.group, further Cox regression analysis was not possible.
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Intraplaque hemorrhage as determined by this MR
technique is a good predictor of recurrent ipsilateral stroke
and TIA in symptomatic mild to moderate carotid stenosis.
This finding held true in this subgroup with symptomatic
moderate (50%-69%) carotid stenosis. This study is there-
fore in accordance with other studies that have used MR to
image intraplaque hemorrhage and adds to the evidence
that intraplaque hemorrhage detected using MR is a clini-
cally important biomarker in patients with symptomatic
carotid disease. In symptomatic arteries, MR detected in-
traplaque hemorrhage predicted the risk of further neuro-
logical events better than the degree of luminal stenosis
(HR 9.8 and 1.5, respectively).
Pooled analyses of the endarterectomy trials4 and the
2006 American Heart Association (AHA) guidelines16
show that the benefits of carotid endarterectomy in this
subgroup depend upon patient-specific factors other than
the degree of stenosis that affect the absolute risk of recur-
rent cerebral ischemia, such as age and gender. Plaque
features such as the integrity of the fibrous cap and the size
of the lipid core are important features contributing to the
stability of the plaque and are found in both symptomatic
and asymptomatic carotid arteries.12,17 Similarly,17 in-
traplaque hemorrhage is present in similar amounts in
carotid plaques from symptomatic and asymptomatic pa-
tients. However, in symptomatic plaques, intraplaque hem-
orrhage correlates strongly with cap rupture.18
Given the amount of information known about MR
detected intraplaque hemorrhage9,10,12,19 and that MR
detected intraplaque hemorrhage in our study was the
single most important predictor of recurrent ipsilateral
cerebral ischemia, this may be one of themost useful factors
in the selection of patients for carotid intervention. If
confirmed in larger studies, the rarity of events seen in the
symptomatic group without ipsilateral carotid MR in-
traplaque hemorrhage (1/25, 4%) raises doubt about the
benefits of carotid endarterectomy in this group.
A caveat to these findings is that high signal was not a
strong predictor of stroke and TIA in asymptomatic arter-
ies: it was commonly found in the asymptomatic, contralat-
eral carotid arteries of our patients, but only one TIA was
observed in the territories supplied by these arteries. It
therefore appears that it is a combination of prior neuro-
logical events and MR high signal that predicts future
events. In the symptomatic carotids, the presence of MR
IPH was similarly predictive of recurrence in both the
moderate and mild stenosis subgroups. It is likely that MR
high signal in asymptomatic arteries represents hemorrhage
into plaque that has not yet ruptured, whereas in symptom-
atic arteries it represents complicated plaque. Further stud-
ies of the exact significance of MR high signal in asymp-
tomatic arteries are warranted.
Since this MRI test can be performed quickly (less than
4 minutes acquisition time), can be analyzed reliably, and
has no requirement for special hardware or software for
image acquisition and interpretation, it is therefore feasibleto examine for MR intraplaque hemorrhage at the same
time as an MRI assessment is made of the intra- and
extracranial carotid arteries and of associated cerebral isch-
emic damage.
Although our findings show the importance of MR
detected intraplaque hemorrhage in predicting ischemic
events, this study was not large enough to test for the more
clinically relevant outcome of stroke (rather than stroke and
TIA), despite recruiting all patients in a large centre for 1
year, and 2 years of follow-up. Furthermore, the confidence
intervals for risk are wide and therefore larger, multicenter,
studies will be required to confirm these findings. Further
studies are required to compare the value and feasibility of
this simple MR technique to identify increased clinical risk
with other plaque biomarkers that might be revealed by
high resolution scanning.20 It may also be useful to com-
pare the MR IPH findings with other simple noninvasive
tests, such as Duplex ultrasound.
We conclude that magnetic resonance imaging of ipsi-
lateral intraplaque hemorrhage is a valuable technique ca-
pable of predicting the behavior of mild to moderately
stenosed symptomatic carotid disease and may be used to
improve patient selection for carotid surgery. Further,
larger studies, powered for a difference in stroke rates and
sufficient to examine the independent effect this biomarker
and other possible risk factors, are warranted in symptom-
atic patients with mild to moderate carotid stenosis. Fur-
ther research is also required to establish the histological
findings in asymptomatic plaque with MR high signal.
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One of the most enduringHoly Grails in carotid practice is the
search for a preoperative biomarker or imaging parameter that
accurately identifies the “high-risk for stroke” patient amongst a
myriad of “lower-risk” patients attending cerebrovascular clinics.
Unfortunately, every attempt has (thus far) failed, and it is inevi-
table that some observers will retain an interested but sceptical
wariness regarding the suggestion by Altaf et al that magnetic
resonance detection of intraplaque hemorrhage (MR-IPH) might
optimize selection for carotid endarterectomy (CEA) or carotid
artery angioplasty and stenting (CAS).
At first sight, the omens seem promising. The Altaf et al data
suggest that MR-IPH in symptomatic patients with mild/moder-
ate disease predicted an increased risk of recurrent ipsilateral events
during a median 28 months’ follow-up. These data are consistent
with earlier observations that MR-IPH correlated positively with
recurrent ipsilateral events in symptomatic patients with 70% to
99% stenoses awaiting CEA1 and an increased rate of particulate
embolization detected during CEA.2
So why do I retain doubts? I genuinely want this type of research
to succeed, as too many CEA/CAS procedures are performed in
otherwise very low-risk patients: seven of 10 symptomatic and nine of
10 asymptomatic interventions are (with hindsight) unnecessary.
However, I keep returning to the anomaly in this paper, which was
also present in an earlier study by Atlaf et al in patients with severe
carotid disease.1 Why is it that MR-IPH was only predictive of
recurrent events in the ipsilateral symptomatic artery and not in the
contralateral asymptomatic artery? In this study, 58% of contralateraledged this discrepancy, but did not offer an explanation other than
noting that coassociation with symptoms was important. Is it possible
that some of the “high signal” in these symptomatic patients repre-
sented fresh luminal thrombus?
So what are my take-home messages? Notwithstanding the
good omens, I need a little more convincing about whether
MR-IPH represents cause or effect in symptomatic and asymptom-
atic patients. Second, I would like to know about temporal changes
in MR-IPH: Is it a constant feature, or does it regress with time or
statin therapy? Third, is MR-IPH associated with increased proce-
dural risks after CAS? Finally, the anomaly regarding MR-IPH in
asymptomatic patients could simply reflect small numbers and
short follow-up. I hope that others—perhaps even the Transatlan-
tic Asymptomatic Carotid Intervention Trial (TACIT)3 with its
randomized medical arm—will undertake corroborative studies in
larger cohorts of patients. The importance of identifying a reliable
preoperative marker of increased stroke risk cannot be understated.
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